North Star Asset Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,778
| Closed | -$77.3K | – | 326 |
|
|
2024
Q2 | $77.3K | Buy |
5,778
+3,578
| +163% | +$47.8K | ﹤0.01% | 305 |
|
|
2024
Q1 | $102K | Buy |
2,200
+646
| +42% | +$30K | ﹤0.01% | 308 |
|
|
2023
Q4 | $105K | Buy |
1,554
+200
| +15% | +$13.5K | 0.01% | 302 |
|
|
2023
Q3 | $98K | Buy |
1,354
+891
| +192% | +$64.5K | 0.01% | 289 |
|
|
2023
Q2 | $34.4K | Sell |
463
-40
| -8% | -$2.97K | ﹤0.01% | 297 |
|
|
2023
Q1 | $26.7K | Sell |
503
-412
| -45% | -$21.9K | ﹤0.01% | 301 |
|
|
2022
Q4 | $61.9K | Buy |
915
+275
| +43% | +$18.6K | ﹤0.01% | 303 |
|
|
2022
Q3 | $80K | Sell |
640
-41
| -6% | -$5.13K | 0.01% | 289 |
|
|
2022
Q2 | $65K | Buy |
+681
| New | +$65K | ﹤0.01% | 290 |
|